My Personal CFO LLC’s Labcorp LH Stock Holding History

My Personal CFO LLC’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	-$235	–	486
2022 Q4	$235	Buy	+1	New	+$195	﹤0.01%	874

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

My Personal CFO LLC's LH Position: Q1 2023 in Review

My Personal CFO LLC sold out of Labcorp (LH) in Q1 2023, closing a stake of 1 share — an estimated $235 sold.

My Personal CFO LLC first reported a position in LH in Q4 2022 and held it in 1 quarter. The position peaked at $235 in Q4 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

My Personal CFO LLC reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
My Personal CFO LLC sold 1 Labcorp share in Q1 2023, an estimated $235.
My Personal CFO LLC first reported a position in Labcorp in Q4 2022 and held it in 1 quarter.
My Personal CFO LLC's Labcorp position peaked at $235 in Q4 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on My Personal CFO LLC's 13F filing for Q1 2023, filed 21 Apr 2023.